Concepedia

Jack P. K. Bravo

JP

23

Publications

1.2K

Citations

17

H-Index

2018

Active since

Affiliations

The University of Texas at Austin(Current)

Livestrong Foundation

Ludwig-Maximilians-Universität München

Center for NanoScience

University of Cambridge

Jack P. K. Bravo is an author at The University of Texas at Austin specializing in medicine, molecular biology, and systems biology.

ORCID

Top concepts

Publications per year

2018–2025

23

Publications

23

Structural basis for mismatch surveillance by CRISPR–Cas9

Jack P. K. Bravo, Mu‐Sen Liu, Grace N. Hibshman et al. · Nature · 2022 · 261 citations · Full text

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Jack P. K. Bravo, Tyler L. Dangerfield, David W. Taylor et al. · Molecular Cell · 2021 · 129 citations · Full text

, , +3

Liquid–liquid phase separation underpins the formation of replication factories in rotaviruses

Florian Geiger, Julia Acker, Guido Papa et al. · The EMBO Journal · 2021 · 124 citations · Full text

SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation

Jurre A. Steens, Yifan Zhu, David W. Taylor et al. · Nature Communications · 2021 · 86 citations · Full text

, , +16

RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2

Jack P. K. Bravo, Thomson Hallmark, Bronson Naegle et al. · Nature · 2023 · 63 citations · Full text

Rows per page

1–5 of 23